Cutting the expenses associated with “low-value” medical tests and treatments — such as unnecessary imaging tests and antibiotics for viral infections that won’t benefit from them — will require a multi-pronged plan targeting insurance companies, patients, and physicians, according to a new article. These efforts transcend economic impact, however, and may also be essential for improving health care quality and patient safety.